Psychoorganische Veränderungen

  • H. B. Stähelin
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 92)

Zusammenfassung

„Jeder möchte alt werden, keiner alt sein.“ Dieser Gemeinplatz widerspiegelt unsere zwiespältige Haltung gegenüber der, dank moderner Medizin und guten Lebensbedingungen fast schicksalhaft sicheren Chance, tatsächlich alt zu werden. Es ist vor allem die Angst vor psychoorganischen Veränderungen, die unser Altwerden überschattet. Angehörige sind erschüttert, wenn sie einen tätigen, arbeitenden, sprechenden, denkenden Menschen zuerst nur subtil, dann immer brutaler auf einige wenige Lebensfunktionen reduziert erleben. Können wir dieses Schicksal voraus oder früh genug erkennen? Wie läßt es sich aufhalten, abwenden oder doch in seinem Lauf günstig gestalten?

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderton BH, Brion JP, Flament-Durand J, Haugh M, Kahn J, Miller CCJ, Probst A, Ulrich J (1986) Changes in the neuronal cytoskeleton in aging and disease. In: Bergener M, Ermini M, Stähelin HB (eds) Dimensions in aging. Academic Press, London (in preparation)Google Scholar
  2. 2.
    Ban TA (1980) Psychopharmacology for the aged. Karger, BaselGoogle Scholar
  3. 3.
    Bartus RT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417 -PubMedCrossRefGoogle Scholar
  4. 4.
    Bingmann D (1984) Lernen und Gedächtnis: Neurophysiologische Grundlagen. Therapiewoche 34:7155–7162Google Scholar
  5. 5.
    Birren JE, Woods AM, Williams MV (1986) Behavioral slowing with age: causes, organization and consequencesGoogle Scholar
  6. 6.
    Bonhoeffer K (1917) Die exogenen Reaktionstypen. Arch Psychiatr Nervenkr 58:58–70CrossRefGoogle Scholar
  7. 7.
    Buonanno FS, Kramer C, Davis KR, Miatto O Kistler JP, Brady TJ, Growdon JH (1985) Comparison of NMR imaging and CT in dementia. 13th Int Congr Gerontol, New York, p 49 (abstract)Google Scholar
  8. 8.
    Bustany P, Sargent T, Sandubray JM, Henry JF, Comar D (1981) Regional human brain uptake and protein incorporation of 11C-l-methionine studied in vivo with PET. J Cerebral Blood Flow Metabol 1 (Suppl 1): 17–18Google Scholar
  9. 9.
    Cummings JL, Benson DF (1986) Dementia of the Alzheimer type. An inventory of diagnostic clinical features. J Am Geriatr Soc 34:12–19PubMedGoogle Scholar
  10. 10.
    Crapper DR, Karlik S, de Boni U (1978) Aluminum and other metals in senile (Alzheimer’s) dementia. Aging 7:471–486Google Scholar
  11. 11.
    De Kosky ST (1984) Recovery of function in senile dementia of the Alzheimertype. In: Scheff SW (ed) Aging and recovery of function in the central nervous system. Plenum Press, New York, pp 207–217Google Scholar
  12. 12.
    Department of Health and Human Service’s (DHHS) (1985) Task force on Alzheimer’s disease: Report and recommendations. Neurobiol Aging 6:65–71CrossRefGoogle Scholar
  13. 13.
    Diagnostisches und statistisches Manual psychischer Störungen (DSM III) (1984) Beltz, Weinheim BaselGoogle Scholar
  14. 14.
    Fields WS (1985) Vascular disease and dementia. Interdiscipl Topics Geront 19:12–17Google Scholar
  15. 15.
    Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state: a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRefGoogle Scholar
  16. 16.
    Gajdusek DC (1984) Interference with axonal transport of neurofilament as the common etiology and pathogenesis of neurofibrillary tangles, amyotrophic lateral sclerosis, parkinsonism-dementia and many other degenerations of the CNS: a series of hypothesis. In: Chen KM, Yase Y (eds) Amyotrophic lateral sclerosis in Asia and Oceania. National Taiwan University Tai Pe, pp 423–436Google Scholar
  17. 17.
    Glen AIM, Whalley LJ (1979) Alzheimer’s disease early recognition of potentially reversible deficits. Churchill Livingstone, Edinburgh, pp 122–128Google Scholar
  18. 18.
    Gottfries CG (1985) Alzheimer’s disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86:245–252PubMedCrossRefGoogle Scholar
  19. 19.
    Gottfries CG (1986) Nosological aspects of differential typology of dementia of Alzheimer type. In: Bergener M, Ermini M, Stähelin HB (eds) Dimensions of aging. Academic Press, London (in preparation)Google Scholar
  20. 20.
    Gurland B, Toner J (1983) Differentiating dementia from nondementing conditions. Advances Neurol 38:1–17Google Scholar
  21. 21.
    Hachinski VC, Lassen NA, Marshall J (1974) Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet ii:207–210CrossRefGoogle Scholar
  22. 22.
    Haxby JV (1985) Cerebral metabolism and neuropsychology in mild and moderate Alzheimer’s disease. 13th Int Congress of Gerontol, New York, p 50 (abstract)Google Scholar
  23. 23.
    Huber G (1984) Organische und symptomatische Psychosen. In: Battegay R, Glatzel J, Pöldinger W, Rauchfleisch U (Hrsg) Handwörterbuch der Psychiatrie. Enke, Stuttgart, S 340–344Google Scholar
  24. 24.
    Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Brit J Psychiatr 140:566–572CrossRefGoogle Scholar
  25. 25.
    Kerzner LJ (1984) Diagnosis and treatment of Alzheimer’s disease. Adv Intern Med, pp 447–470Google Scholar
  26. 26.
    Larsen EB, Reifler BV, Featherstone HJ, English DR (1984) Dementia in elderly outpatients: a prospective study. Ann Int Med 100:417–423CrossRefGoogle Scholar
  27. 27.
    Little A, Levy R, Chuaqui-Kidd P, Hand D (1985) A double blind, placebo controlled trial of high-dose lecithin in Alzheimer-disease. J Neurol Neurosurg Psychiatr 48:736–742PubMedCrossRefGoogle Scholar
  28. 28.
    McKhann G, Drachman D, Folstein D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease. Neurology 34:939–944PubMedCrossRefGoogle Scholar
  29. 29.
    Meier-Ruge W, Ulrich J, Stähelin HB (1985) Morphometry investigation of nerve cells, neuropil and senile plaques in senile dementia of the Alzheimer type. Arch Gerontol Geriatr 4:219–229PubMedCrossRefGoogle Scholar
  30. 30.
    Mundt CH (1984) Defekt. In: Battegay R, Glatzel J, Pöldinger W, Rauchfleisch U (Hrsg) Handwörterbuch der Psychiatric Enke, Stuttgart, pp 101–104Google Scholar
  31. 31.
    Österreich K (1984) Altersdiagnostik. In: Battegay R, Glatzel J, Pöldinger W, Rauchfleisch U (Hrsg) Handwörterbuch der Psychiatric Enke, Stuttgart, S 20–23Google Scholar
  32. 32.
    Rahmann H (1984) Lernen und Gedächtnis vom Standpunkt der Neurobiologie. Therapiewoche 34:7139–7154Google Scholar
  33. 33.
    Rogers J, Shoemaker WJ, Bloom FE (1985) Neurotransmitterveränderungen im alternden Gehirn. In: Heidrich H (Hrsg) Therapeutische Wirksamkeitsnachweise bei nootropen und vasoaktiven Substanzen. Springer, Berlin, S 69–113 -CrossRefGoogle Scholar
  34. 34.
    Remschmidt, H (1985) Persönlichkeitsveränderungen, Affektivität und Antrieb. In: Bente P, Coper H, Kanowski S (Hrsg) Hirnorganische Psychosyndrome im Alter II. Springer, Berlin, S 9–23CrossRefGoogle Scholar
  35. 35.
    Reisberg B, Terris SH, de Leon MJ, Crook D (1985) Age-associated cognitive decline and Alzheimer’s disease: implications for assessment and treatment. In: Bergener M, Ermini M, Stähelin HB (eds) Thresholds in aging. Academic Press, London, pp 255–291Google Scholar
  36. 36.
    Sing R (1985) Zur Erfahrungsrepräsentation im Gehirn -psychophysiologische Grundlagen zur Erforschung und Diagnostik des hirnorganischen Psychosyndroms. In: Bente D, Coper H, Kanowski S (Hrsg) Hirnorganische Psychosyndrome im Alter IL Springer, Berlin S 45–72Google Scholar
  37. 37.
    Stähelin HB, Hew-Winzeler AM, Behrens D, Seiler WO, Ulrich J (1984) Unsolved clinical problems in advanced senile dementia. In: Wertheimer J, Marvis M (Hrsg) Senile Dementia: Outlook for the future. Alan Liss, New York, pp 269–277Google Scholar
  38. 38.
    The Royal College of Physicians by the College Committee on Geriatrics (1981) Organic mental impairment in the elderly: implications for research, education and the provision of services. J Royal Coll Phys 15:152–167Google Scholar
  39. 39.
    Trapp GA, Miner GD, Zimmerman RL, Mastri AR, Heston LH (1978) Aluminum levels in brain in Alzheimer’s disease. Biol Psychiat 13:709–718PubMedGoogle Scholar
  40. 40.
    U’Ren RC (1984) Organic disorders. In: Cassel CK, Walsh JR (eds) Geriatric Medicine I. Springer, New York, pp 553–576Google Scholar
  41. 41.
    WHO Study Group (1981) Neuronal aging and its implications in human neurological pathology. Technical Report Series 665, WHO Geneva, pp 7–85Google Scholar
  42. 42.
    Winblad B, Wallace W, Hardy J, Fowler C, Bucht G, Alafuzoff I, Adolfson R (1986) Neurochemical, genetic and clinical aspects of Alzheimer’s disease. In: Bergener M, Ermini M, Stähelin HB (eds) Dimensions of aging. Academic Press, London (in prep.)Google Scholar
  43. 43.
    Wurtman RJ (1985) Alzheimer’s disease. Scient Am 252:48–56CrossRefGoogle Scholar
  44. 44.
    Wyatt RJ, Freed WJ, Medinaceli L de (1986) Promoting functional plasticity in the adult nervous system. In: Bergener M, Ermini M, Stähelin HB (eds) Dimensions in aging. Academic Press, London (in preparation).Google Scholar

Copyright information

© J. F. Bergmann Verlag, München 1986

Authors and Affiliations

  • H. B. Stähelin
    • 1
  1. 1.Medizinisch-Geriatrische KlinikenKantonsspital und Felix Platter SpitalBaselSchweiz

Personalised recommendations